Clinical trial · Interventional
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy----A Multi-center Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this randomized controlled clinical trial is to investigate the effects of epidural block on overall survival,disease-free survival and recovery in patients with pancreatic cancer undergoing distal pancreatectomy. This study will also evaluate the effects of this technique on neuroendocrine, stress and inflammatory response in these patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| GA | Other | — | UNRESOLVED |
| GEA | Other | — | UNRESOLVED |
| PCEA | Other | — | UNRESOLVED |
| PCIA | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- GEA+PCEA
- description
- General anesthesia combined with epidural anesthesia will be performed during surgery and patient-controlled epidural analgesia (PCEA) will be provided after surgery.
- interventionNames
- Other: GEA
- Other: PCEA
- type
- OTHER
- label
- GA+PCIA
- description
- General anesthesia will be performed during surgery and patient-controlled intravenous analgesia (PCIA) will be provided after surgery.
- interventionNames
- Other: GA
- Other: PCIA
Primary outcomes (1)
- measure
- Overall survival (OS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Undergoing elective distal pancreatectomy for pancreatic cancer . 2. ASA statusⅠ-Ⅲ. 3. 18 years to 80 years (adults). 4. Able to understand, communicate and sign an informed consent form. Exclusion Criteria: 1. Laparoscopic surgery. 2. Preoperative chemotherapy or radiotherapy. 3. Pregnancy. 4. Allergic to any drugs used during the study. 5. Long-term receiving β-blockers. 6. Complicated with chronic inflammatory diseases, autoimmune diseases, or long-term receiving glucocorticoids or other immunosuppressants before surgery. 7. Abnormal coagulation functions (platelet count prior to surgery \<100000/ μL , APTT value is more than the normal value, INR \> 1.3 or clopidogrel that cannot be discontinued 7 days prior to surgery). 8. Complicated with severe heart disease (NYHA classification \>3), severe renal insufficiency (serum creatinine \>1.8mg/dL or receiving renal replacement therapy), severe hepatic disease (Child-Pugh classification=C), diabetes (fasting blood glucose not in the range of 3.9-13.8 mmol/L ), or acute infectious diseases (WBC\>10000/μL) before surgery. 9. BMI \> 35. 10. All contraindications to epidural block. 11. Chronic opiate medication/drug abuse. 12. Complicated with severe mental illness, cognitive disorder or unable to collaborate during the study. 13. Refuse to sign an informed consent form.
References
Publications (0)
Data not yet available